Trial Profile
Evaluation of Clinical Efficacy and Immunologic Response After Iguratimod Therapy in Refractory Lupus Nephritis
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 May 2019
Price :
$35
*
At a glance
- Drugs Iguratimod (Primary)
- Indications Lupus nephritis
- Focus Therapeutic Use
- 21 Feb 2017 New trial record